Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy
Supportive Care in Cancer, 08/13/09
Ramírez-Amador V et al. - In a study to characterize clinical features, associated risk factors, and behavior of oral mucositis (OM) in a cohort of acute leukemia (AL) pts starting chemotherapy (CT), it was determined that OM is a frequent and early side effect of CT closely correlated with oral pain, difficulty to swallow, and impairment in food intake.
Methods- Pts older than 15 yrs of age with AL, scheduled to receive CT, were followed.
- At baseline and 3 times per wk, for 21 days, pts had an oral examination performed using the Oral Mucositis Assessment Scale (OMAS); also, oral pain and difficulty to swallow were recorded using a visual analog scale.
- Wkly, salivary flow measurements (Schirmer’s test modified version) were done.
- 29 AL pts were followed for a median of 21 (range, 14–53) days; 12 (41.4%) developed OM, with a mean OMAS score of 0.181 and a mean peak OMAS score of 1.8.
- OM onset mean time was 9.8 (range, 2–20) days, with a mean duration of 7 (range, 3–14) days.
- OM was significantly correlated with salivary flow, oral pain, ability to swallow, and type of food intake.
Related Articles
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09
Relevance Score: 82%
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09
Relevance Score: 81%
FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09
Relevance Score: 81%
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF
American Journal of Hematology, 10/13/09
Relevance Score: 81%
Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F-protocol
Pediatric Blood & Cancer, 10/09/09
Relevance Score: 81%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil
Medical Oncology, 12/03/09
Intravascular lymphocytosis in acute appendicitis: potential mimicry of chronic lymphocytic leukaemia
Histopathology, 12/03/09
Clinicopathological characteristics of primary gastric T-cell lymphoma
Histopathology, 12/03/09
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
The Oncologist, 12/03/09
Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study)
Clinical and Translational Oncology, 11/25/09
Hemorrhagic Gastritis and Duodenitis Following Celiac Plexus Neurolysis
Pain Physician, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


